NDC 73309-262 - Sorafenib
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 73309-262
- Package NDCs from labels
- 73309-262-01
- Manufacturer
- BLUEBAY SHANDONG CO.,LTD
- Effective date
- 2021-03-09
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Sorafenib - BLUEBAY SHANDONG CO.,LTD | BLUEBAY SHANDONG CO.,LTD | 2021-03-09 | BULK INGREDIENT |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 73309-262-01 | Sorafenib | 100 g in 1 JAR | POWDER | 100 | 1 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| sorafenib | SORAFENIB | Golden State Medical Supply, Inc. | faa9d847-2cd5-6538-e053-6394a90aa92b | 2026-07-28 | Warnings, Adverse reactions | 9ZOQ3TZI87 |
| sorafenib | SORAFENIB | Upsher-Smith Laboratories, LLC | 68aa4b7f-3f13-4e73-b572-aa6c11a8429c | 2026-07-03 | Warnings, Adverse reactions | 9ZOQ3TZI87 |
| sorafenib | SORAFENIB | Yabao Pharmaceutical Co., Ltd. Beijing | 06f442d6-071e-4081-b7f7-40f3b803ab3f | 2026-06-01 | Warnings, Adverse reactions | 9ZOQ3TZI87 |
| Sorafenib | SORAFENIB | Torrent Pharmaceuticals Limited | b5305e23-7bc6-44d8-b177-930c47d1653a | 2026-02-11 | Warnings, Adverse reactions | 9ZOQ3TZI87 |
| Nexavar | SORAFENIB | Bayer HealthCare Pharmaceuticals Inc. | b50667e4-5ebc-4968-a646-d605058dbef0 | 2023-08-28 | Warnings, Adverse reactions | 9ZOQ3TZI87 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.